首页> 外国专利> Pharmacological synthesis of mixtures of human insulin Gly (A21) - Arg (B31) Arg (B32) and isopropene-4 (1-39) - lys6-nh2

Pharmacological synthesis of mixtures of human insulin Gly (A21) - Arg (B31) Arg (B32) and isopropene-4 (1-39) - lys6-nh2

机译:人胰岛素Gly(A21)-Arg(B31)Arg(B32)和异丙烯4(1-39)-lys6-nh2的混合物的药理合成

摘要

It refers to a kind of drug synthesis including insulin and GLP-1 agent, in which insulin is the insulin of Gly (A21) - Arg (B31) - Arg (B32) people, Lys @ b28pro @ B29 human insulin, B28 ASP people's insulin or b29lys (epsilon tetradecanoil), or 30 people's insulin and GLP-1 agent abusers, exendina-4, exendina-3, Among others, there was no 36 exendina-4 (1-39) - lys6-nh2. This component is useful for the treatment of type 1 or type 2 diabetes. It can adjust the concentration of blood glucose in fasting, postpartum and / or posabortiva, improve glucose tolerance, etc.
机译:它是指包括胰岛素和GLP-1剂在内的一种药物合成,其中胰岛素是Gly(A21)-Arg(B31)-Arg(B32)人的胰岛素,Lys @ b28pro @ B29人胰岛素,B28 ASP人的胰岛素胰岛素或b29lys(ε十二烷油),或30个人的胰岛素和GLP-1药物滥用者,exendina-4,exendina-3,其中不存在36个exendina-4(1-39)-lys6-nh2。该成分可用于治疗1型或2型糖尿病。它可以调节空腹,产后和/或腹泻中的血糖浓度,提高葡萄糖耐量等。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号